Synthesis and Characterization of PEGylated Toll Like Receptor 7 Ligands-Reference-Cited by-同舟云学术

Synthesis and Characterization of PEGylated Toll Like Receptor 7 Ligands

Published:2011-02-21 Issue:3 Volume:22 Page:445-454
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Chan Michael¹,Hayashi Tomoko¹,Mathewson Richard D.¹,Yao Shiyin¹,Gray Christine¹,Tawatao Rommel I.¹,Kalenian Kevin¹,Zhang Yanmei¹,Hayashi Yuki¹,Lao Fitzgerald S.¹,Cottam Howard B.¹,Carson Dennis A.¹

Affiliation:

1. Moores Cancer Center, University of California San Diego, 3855 Health Science Drive, La Jolla California 92093-0820, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc1004813

Reference27 articles.

1. Recognition of pathogen-associated molecular patterns by TLR family

2. Toll-like receptor signalling

3. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA

4. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple-transformable dynamic surroundings for programmed transportation of bio-vulnerable mRNA payloads towards systemic treatment of intractable solid tumors;Biomaterials;2024-12

2. TLR Agonists Delivered by Plant Virus and Bacteriophage Nanoparticles for Cancer Immunotherapy;Bioconjugate Chemistry;2023-08-23

3. Glyco-Nanoadjuvants: Impact of Linker Length for Conjugating a Synthetic Small-Molecule TLR7 Ligand to Glyco-Nanoparticles on Immunostimulatory Effects;ACS Chemical Biology;2022-03-30

4. Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants;Advanced Drug Delivery Reviews;2021-08

5. A tractable covalent linker strategy for the production of immunogenic antigen-TLR7/8L bioconjugates;Chemical Communications;2021